Neoscreen was founded in 2007 and it is involved in the development and application of genetics test
regarding prenatal testing, carrier screening (testing for future parents), hereditary cancer syndromes,
congenital heart diseases, pharmacogenomics profiling (effect of genotype on drug response) as
well as expanded neonatal screening. In addition, Neoscreen offers whole genome sequencing as a
diagnostic tool for serious diseases. Since its establishment it collaborates with private hospitals
(IASO, IASO Thesallia, REA, GAIA, EUROPEAN INTERBALKAN MEDICAL CENTER), In Vitro Fertilization (IVF) centers, doctors, stem cell companies (Omnigen), the Breast Center in Ippokrateio Hospital under t...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
